您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:中国中药中期报告 2024 - 发现报告

中国中药中期报告 2024

2024-09-26港股财报乐***
中国中药中期报告 2024

2024 2327303132343536 2881601 (852) 2854 3393(852) 2544 1269publicrelation@china-tcm.com.cn 00570 97927 183171712-1716 www.china-tcm.com.cn 20246302023 8,385,473,0009,302,957,0009.9%754,277,0009.0%1,576,914,00018.8%3,479,735,00041.5%2,418,349,00028.8%156,198,0001.9% 4,061,254,0004,757,976,00014.6%48.4%51.1%2.7 CCTV-1CCTV-8110• 20246 30ESGESG10025 GAP2317841.598234,688.532024630GAP210105108 •31.7%31.3%27%•2024630122720246,05242.8% 447 1993202111 20050% OTC14.2% 152932.5%9 2440021.6% 1218% 1CNASCNAS7Nature6 ISO/TC2491 311961%202463029615753% 64392413147 +4778.7%192739 20242024 +2.02023 1086415478 20241 10 20241 12 20242 5 20242 27 20243 72024 20243 29 20244 22 20245112024 20245 13 2024514 20245 202024 20245246 20245 27142024 20245 27 20245 292024-2027 20245 30 20246 62024 20246 26202452024712024112024 2024 GAP 1+4+N 8,385,473,0009,302,957,0009.9% 754,277,000880,585,00014.3%9.0%1(2) 8.4%8.0%0.4 2. 1,576,914,0001,305,191,00020.8%18.8%(1)(2) 21.1%21.9%0.8 3. 3,479,735,0004,930,591,00029.4%41.5%(1)(2) 59.1%64.1%5.0 4. 2,418,349,0002,034,759,00018.9%28.8%50% 64.7%59.3%5.4 156,198,000151,831,0002.9%1.9% 26.5%22.4%4.1 202463079,597,00083,130,0004.2%16,320,00031,301,00047.9% 202463064,768,000202363014,004,000(1)52,708,000312,000(2)920,000 2024630158,768,00047,768,00020246 306.7% 20246302,752,658,00020236303,186,920,00013.6% 2024630512,150,0002023630464,754,00010.2% 2024630267,925,000313,614,00014.6%(1)(2)(3) 202463084,274,0002023630105,438,0002.8%20236302.7% 2024630874,0001,796,000 2024630214,143,000616,960,00065.3%2.6%6.6%4.0(1)(2)(3) 20246304.1911.4963.5%63.5%210,979,0002023630578,742,000 20246 3020,552,746,000202312 3119,799,846,0003,771,999,000202312313,267,276,000168,178,00020231231249,958,00010,258,088,000202312 319,686,644,0009,888,531,000202312 319,332,600,00010,664,215,000202312 3110,467,246,0002.1202312312.12023123123.9%24.4% 20246304,009,484,000202312313,034,020,0001,232,747,000202312 31535,783,0003,293,149,000716,335,000202312312,120,207,000913,813,000 2024630168,178,00061,727,000680,226,000221,610,000202312 31249,958,00091,902,000672,502,000213,481,000 20248202484202463010,035,352,000 2024630209,351,000356,700,000 20246 30112,628,000202312 31152,870,000 20246 3020231231 20246302024630 202463017,71620236 3017,3735,8146,5115,3911,174,466,00020236301,119,553,000 20242 21622673 8.22(i)(7)(ii)2024102520241018(7)20243112024411202451320246 1320247152024815 6302023630 20246 30XVXV78352C3 20246 30336 1.1,634,705,642 3362024630 2024630 2024630C1 C3 202320243 2113.51B(1) 20246 302024 2024828 3158343434 2410 34 中期簡明合併損益及其他全面收益表 截至二零二四年六月三十日止六個月 中期簡明合併財務狀況表 二零二四年六月三十日 中期簡明合併財務狀況表 二零二四年六月三十日 中期簡明合併現金流量表 截至二零二四年六月三十日止六個月 1. 34 436 662(3)63406(2)407(2)407(3) 2. 161177 中期簡明合併財務資料附註 二零二四年六月三十日 3. i.ii.iii.iv. 3. 中期簡明合併財務資料附註 二零二四年六月三十日 3. 3. 中期簡明合併財務資料附註 二零二四年六月三十日 3. (ii) 8 4. (i) 中期簡明合併財務資料附註 二零二四年六月三十日 4. (ii) 5. (i) (ii) 6. (i)9 7. 中期簡明合併財務資料附註 二零二四年六月三十日 8. 9. 25%15% (i) 10. 中期簡明合併財務資料附註 二零二四年六月三十日 11. 210,979,000578,742,0005,035,801,0005,035,801,000 12. 48,931,00089,144,000160,389,000266,259,000 2,133,0002,581,0001,752,00048,000 680,226,000672,502,000 30501101242,160,0002,704,00040,841,0002,792,000 61,727,00091,902,000 13. 中期簡明合併財務資料附註 二零二四年六月三十日 14. 164,095,000125,485,000 15. 15. 中期簡明合併財務資料附註 二零二四年六月三十日 17. 221,610,000213,481,000 18. (a) 0.2%1.85%0.20%1.80% (b) 3,438,433,0002,986,819,0000.2%1.65%0.10%2.00% 165,388,00030,499,000153,656,00019,661,000 10,495,00013,789,0002,730,0001,813,000 20. 3,199,149,0002,896,277,0002,216,596,000888,414,0000.9%4.75%6 中期簡明合併財務資料附註 二零二四年六月三十日 21. 800,000,0002702.32% 1,200,000,0003.04% 22. 23. 24. 25. 中期簡明合併財務資料附註 二零二四年六月三十日 26. (a) (b) 26. (c) (d) 中期簡明合併財務資料附註 二零二四年六月三十日 26. 27. • •1• 27. 28.